AMPHASTAR PHARMACEUTICALS INAMPH

Bullish

ASignal's systematic analysis rates AMPH as Bullish.

Reflects the latest available analysis · analyzed Sep 22, 2026

The case on AMPH

Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.

Bull case
  • Free cash flow of $230.10M indicates strong cash generation
  • Gross margin of 47.69% reflects pricing power and efficient production
  • Forward P/E of 7.69x suggests valuation discount relative to growth potential
  • Debt-to-equity ratio of 0.90x is manageable and below 1.0 threshold
  • Current ratio of 2.40x indicates solid short-term financial health
VS
Bear case
  • MACD histogram is negative (-0.0188), signaling weakening bullish momentum
  • RSI at 63.26 is approaching overbought territory, limiting near-term upside
  • No Reddit mentions, indicating low retail investor interest or visibility
  • Revenue growth at 5.4% and earnings growth at 4.7% are moderate, not high-growth
  • PEG ratio not available, limiting growth-adjusted valuation assessment
Subscriber-only

See the full verdict on AMPH

ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.

How ASignal analyzes AMPH

Most investors never get a second opinion, let alone several. ASignal runs AMPH past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.

The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.

AMPHASTAR PHARMACEUTICALS IN (AMPH) Stock Analysis - ASignal rates it Bullish